MEDICAL SOCIETIES REPRESENTATIVES’ MEETING ON BIOLOGICAL MEDICINES CONCLUSIONS
Journal Title: Management in Sanatate - Year 2017, Vol 21, Issue 1
Abstract
This position document aims to underline the specificities of biological products, both originals and biosimilars, reflecting in the same time the 9 Scientific Societies’ position on biological medicines’ safe usage for patients.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP288854
- DOI -
- Views 63
- Downloads 0
ENSURING CONSTITUTIONAL AUTHORITY- CONTINUITY OF U.S. GOVERNMENT
The continuity of government (COG) task area of homeland security includes providing for the continuity and restoration of all levels of government - federal, state, and local. [1] For a host of reasons the import...
STILLBIRTHS IN EUROPE – SIGNIFICANT PUBLIC HEALTH PROBLEM
BACKGROUND Together with the achievements and efforts for further reduction of infant mortality and under-five-mortality the stillbirths remain a significant global public health problem. In 2015 the estimated number of...
HOSPITALIZATION BY THE FREQUENTLY CANCERS IN ADULTS OVER 18 YEARS, IN PUBLIC HOSPITALS IN ROMANIA
In Romania, the standardized mortality rate for colorectal cancer was superior to the European Union and the hospital discharge rate for these patients in our country was above the European average in 2016. In terms of p...
MEDICAL SOCIETIES REPRESENTATIVES’ MEETING ON BIOLOGICAL MEDICINES CONCLUSIONS
This position document aims to underline the specificities of biological products, both originals and biosimilars, reflecting in the same time the 9 Scientific Societies’ position on biological medicines’ safe usage for...
OPTIMIZING E-PROCUREMENT IN HOSPITALS: A PRACTICAL FRAMEWORK
Although hospitals need to utilize expertise and technology in order to enhance their sourcing processes, the diffusion of e-procurement appears to be relatively slow. Case study based research identified the need for pr...